New Edge Wealth, LLC Gilead Sciences, Inc. Transaction History

New Edge Wealth, LLC

$5.41 Billion
Q3 2024

A detailed history of New Edge Wealth, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, New Edge Wealth, LLC holds 374,574 shares of GILD stock, worth $33.8 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

374,574

Previous 370,487 1.1%

Holding current value

$33.8 Million

Previous $25.4 Million 23.51%

% of portfolio

0.58%

Previous 0.56%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$66.59 - $83.99 $272,153 - $343,267	4,087 Added 1.1%	374,574 $31.4 Million
Q2 2024 Aug 01, 2024	SELL	$63.15 - $72.88 $438,450 - $506,005	-6,943 Reduced 1.84%	370,487 $25.4 Million
Q1 2024 May 06, 2024	BUY	$71.58 - $87.29 $2.68 Million - $3.27 Million	37,463 Added 11.02%	377,430 $27.6 Million
Q4 2023 Jan 29, 2024	BUY	$73.27 - $83.09 $2.02 Million - $2.29 Million	27,572 Added 8.83%	339,967 $27.5 Million
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $3.49 Million - $3.8 Million	47,137 Added 17.77%	312,395 $23.4 Million
Q2 2023 Aug 09, 2023	BUY	$76.01 - $86.7 $6.17 Million - $7.04 Million	81,231 Added 44.14%	265,258 $20.4 Million
Q1 2023 May 08, 2023	BUY	$77.31 - $88.08 $7.56 Million - $8.61 Million	97,736 Added 113.26%	184,027 $15.3 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $241,427 - $346,606	3,874 Added 4.7%	86,291 $7.41 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $1.39 Million - $1.59 Million	-23,415 Reduced 22.12%	82,417 $5.08 Million
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $1.91 Million - $2.15 Million	33,126 Added 45.56%	105,832 $6.54 Million
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $354,991 - $444,842	6,129 Added 9.21%	72,706 $4.32 Million
Q4 2021 Jan 31, 2022	BUY	$64.88 - $73.64 $325,113 - $369,010	5,011 Added 8.14%	66,577 $4.83 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $4.17 Million - $4.5 Million	61,566 New	61,566 $4.3 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Wealth, LLC with notifications on news.

Account

New Edge Wealth, LLC Gilead Sciences, Inc. Transaction History